Oncolys BioPharma: Announcements of individual stocks: Complete registration of Phase I clinical trial of telomelysin and chemical radiation combination therapy.

JPX · Aug 6 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.